Tandem Diabetes Care, Inc. (TNDM) News
Filter TNDM News Items
TNDM News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
TNDM News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest TNDM News From Around the Web
Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.
Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems. |
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery SystemsSAN DIEGO, January 07, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA) to advance research and development efforts on fully automated closed-loop insulin delivery systems. |
Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?Inari Medical (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. |
Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Trading At A 46% Discount?Key Insights Using the 2 Stage Free Cash Flow to Equity, Tandem Diabetes Care fair value estimate is US$66.97 Current... |
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in CanadaTandem Diabetes' t:slim X2 insulin pump is now compatible with Dexcom G7 CGM in Canada. |
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in CanadaMARKHAM, Ontario, December 10, 2024--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ insulin pump users can now access full compatibility with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems. The t:slim X2 insulin pump with Control-IQ technology is the #1-rated automated insulin delivery (AID) system1, and now the first and only insulin pump in Canada t |
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Reasons to Retain TNDM Stock in Your Portfolio for NowInnovations and a robust international market expansion raise investors' optimism for Tandem Diabetes. |
Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In NowWe recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look at where Tandem Diabetes Care, Inc. (NASDAQ:TNDM) stands against the other oversold healthcare stocks. The Promising Outlook for Healthcare Investments in 2024 Investing in healthcare stocks during lean economic times is generally […] |
Tandem Diabetes Care Announces Upcoming Conference PresentationsSAN DIEGO, November 21, 2024--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: |